Filing Details
- Accession Number:
- 0000899243-21-035731
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-13 19:27:07
- Reporting Period:
- 2021-09-10
- Accepted Time:
- 2021-09-13 19:27:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1651308 | Beigene Ltd. | BGNE | Biological Products, (No Disgnostic Substances) (2836) | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 318154 | Amgen Inc | One Amgen Center Drive Thousand Oaks CA 91320 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| American Depositary Shares | Acquisiton | 2021-09-10 | 165,529 | $302.06 | 18,943,802 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This transaction was made pursuant to that Share Purchase Agreement, dated as of September 24, 2020, as amended, by and between the Reporting Person and the Issuer.
- The price reported is the volume weighted average price on the NASDAQ Stock Market LLC of one American Depositary Share ("ADS") of the Issuer for the ninety calendar days preceding August 31, 2021.
- As each ADS represents 13 Ordinary Shares of the Issuer, the reported securities represent 246,269,426 Ordinary Shares.
Billionaire Hedge Funds
